What are the risk factors for pulmonary embolism (PE) besides recent travel?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk Factors for Pulmonary Embolism Beyond Travel

The most significant risk factors for pulmonary embolism (PE) beyond travel include surgery, immobility, malignancy, pregnancy/postpartum state, older age, thrombophilia, and hormone therapy. 1

Major Risk Factors

Surgical and Medical Conditions

  • Major orthopedic lower limb surgery and postoperative intensive care are associated with a high risk of PE 1
  • Immobility due to stroke, neurological diseases (brain tumors, acute spinal injury), and prolonged hospitalization significantly increases PE risk 1
  • Cardiorespiratory disorders, particularly myocardial infarction, congenital heart disease, congestive heart failure, and irreversible airways disease are major risk factors 1

Malignancy

  • Cancer, especially of the uterus, pancreas, breast, and stomach, as well as advanced and metastatic disease, significantly increases PE risk 1
  • The association between PE and occult malignancy is significant, with many patients diagnosed with PE later found to have previously undetected cancer 1

Demographic and Physical Factors

  • Age is a significant risk factor, with PE risk increasing exponentially with age, particularly over 40 years 1
  • Obesity has been confirmed as an independent risk factor for PE 1

Hormonal and Pregnancy-Related Factors

  • Estrogen therapy increases PE risk, especially with "third generation" agents 1
  • Pregnancy and postpartum state carry increased risk, particularly with pre-eclampsia, cesarean section, and multiple births 1
  • While oral contraceptives increase risk 2-4 times compared to controls, the absolute risk remains low with current low-dose formulations 1

Thrombophilia

  • Inherited or acquired thrombophilia (antiphospholipid syndrome, deficiencies of antithrombin III, factor V Leiden, protein C, or protein S) is found in 25-50% of patients with PE 1
  • These thrombophilic factors typically need to interact with acquired risk factors before thrombosis occurs 1, 2
  • Factor V Leiden mutation, present in 5% of the population and 20% of patients with thrombosis, increases PE risk 3-5 fold, but in combination with estrogen therapy, this risk rises to 35-fold 1

Other Risk Factors

Vascular Access and Procedures

  • Central venous catheterization can lead to PE, though these are rarely fatal, likely because the iatrogenic clot is too small to cause major pulmonary vascular occlusion 1
  • Upper limb spontaneous clots are less common and rarely lead to PE compared to lower limb thrombosis 1

Multiple Risk Factors

  • The incidence of PE is particularly high when multiple risk factors are present 1
  • Risk factors often interact synergistically rather than additively 1, 2

Clinical Implications

Risk Assessment

  • All patients with possible PE should have clinical probability assessed and documented 1
  • The presence of risk factors significantly influences the pre-test probability of PE and should guide diagnostic strategies 1

Common Pitfalls

  • Not recognizing that PE risk increases exponentially with age 1
  • Failing to consider thrombophilia in patients with unexplained thrombotic episodes, especially those occurring at a young age or with recurrence 2
  • Overlooking the synergistic effect of multiple risk factors (e.g., oral contraceptives plus Factor V Leiden) 1
  • Underestimating the significance of immobility as a risk factor, which extends beyond travel to include hospitalization and neurological conditions 1

Understanding these risk factors is crucial for appropriate risk stratification, which guides both diagnostic approaches and management decisions in patients with suspected PE 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Thrombophilic Factor Deficiencies and Pulmonary Embolism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.